Company / Gross Profit
Amneal Pharmaceuticals, Inc. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.1B
FY2025
5-year range
$353.0M / $1.1B
FY2021-FY2025
Trend
+9.1%
vs FY2024
Sector context
#9 of 29
Health Care
What the data says
At $1.1B, Amneal Pharmaceuticals, Inc.'s gross profit ranks #9 of 29 in the Health Care sector. Gross Profit has fluctuated over the past 10 years, ranging from $353M in FY2021 to $1.1B in FY2025.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +9.2%.
Improved from $769M to $1.1B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
#9 of 29 in Health CareTop 31% of 29This company $1.1B Sector average $3.5B
▼
-67.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.2%, indicating consistent growth.
- In FY2025, gross profit increased 9.1% year-over-year.
- Ranks #9 out of 29 companies in the Health Care sector.
- Lowest gross profit in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +9.1% |
| FY2024 | $1.0B | +32.7% |
| FY2023 | $769.0M | -2.0% |
| FY2022 | $784.7M | +122.3% |
| FY2021 | $353.0M | -50.7% |
| FY2020 | $716.4M | +36.2% |
| FY2019 | $526.2M | -11.9% |
| FY2018 | $597.5M | +13.5% |
| FY2017 | $526.2M | -11.9% |
| FY2016 | $597.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026